Clinical Trial Update: Study to Assess the Efficacy, Safety and Pharmacokinetic of Octafibrin in Paediatric Subjects With Fibrinogen Deficiency [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating Octafibrin for pediatric fibrinogen deficiency has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Fibrinogen Deficiency

Drugs mentioned

• Octafibrin

Snippet

Sponsor: Octapharma | Conditions: Congenital Fibrinogen Deficiency | Phase 3 | Status: COMPLETED | Results posted: 2020-06-11